129 related articles for article (PubMed ID: 6120738)
61. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
[TBL] [Abstract][Full Text] [Related]
62. A comparative study of misoprostol and ranitidine in the healing of duodenal ulcers. A double-blind controlled trial.
Simjee AE; Spitaels JM; Pettengell KE; Manion GL
S Afr Med J; 1987 Jul; 72(1):15-7. PubMed ID: 3110981
[TBL] [Abstract][Full Text] [Related]
63. [Cimetidine versus ranitidine in the treatment of peptic esophagitis].
Noya G; Dettori G; Muscas A; Spirito R; Niolu P; Marongiu G; Biglioli P
Minerva Med; 1983 Apr; 74(14-15):787-90. PubMed ID: 6132354
[TBL] [Abstract][Full Text] [Related]
64. [Effects of a new histamine H2-receptor antagonist, ranitidine, on experimental acute gastric and duodenal ulcers (author's transl)].
Okabe S; Kunimi H; Ohtsuki H
Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):397-406. PubMed ID: 6116654
[TBL] [Abstract][Full Text] [Related]
65. Comparison of famotidine 40 mg with ranitidine 300 mg at night in short-term duodenal ulcer healing. A South African multicentre study.
Marks IN; Wright JP
S Afr Med J; 1987 Jul; 72(1):18-20. PubMed ID: 2885928
[TBL] [Abstract][Full Text] [Related]
66. Ebrotidine versus ranitidine in the treatment of acute duodenal ulcer. A multicentre, randomized, double-blind, controlled clinical trial.
Matov V; Metchkov G; Krastev Z; Tchernev K; Mitova R; Márquez M; Torres J; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):555-9. PubMed ID: 9205764
[TBL] [Abstract][Full Text] [Related]
67. Ranitidine in the treatment of peptic ulcer.
Makalinao AU; Zaño FM
Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
[TBL] [Abstract][Full Text] [Related]
68. Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs.
Di Mario F; Gottardello L; Germanà B; Dotto P; Grassi SA; Vianello F; Battaglia G; Leandro G; Burra P; Salvagnini M
Ital J Gastroenterol; 1992; 24(3):122-5. PubMed ID: 1348650
[TBL] [Abstract][Full Text] [Related]
69. [Treatment of duodenal ulcer with famotidine].
Schütze K; Hentschel E; Reichel W; Kerstan E
Wien Med Wochenschr; 1987 Sep; 137(17):409-11. PubMed ID: 2891224
[TBL] [Abstract][Full Text] [Related]
70. Reducing overnight secretion of acid to heal duodenal ulcers. Comparison of standard divided dose of ranitidine with a single dose administered at night.
Colin-Jones DG; Ireland A; Gear P; Golding PL; Ramage JK; Williams JG; Leicester RJ; Smith CL; Ross G; Bamforth J
Am J Med; 1984 Nov; 77(5B):116-22. PubMed ID: 6095655
[TBL] [Abstract][Full Text] [Related]
71. [Ranitidine, a newly developed histamine H2-receptor antagonist. First experimental and clinical results].
Simon B; Dammann HG; Müller P; Kather H
Dtsch Med Wochenschr; 1980 Dec; 105(50):1753-5. PubMed ID: 6108203
[No Abstract] [Full Text] [Related]
72. Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin.
Mohammed R; Holden RJ; Hearns JB; McKibben BM; Buchanan KD; Crean GP
Gut; 1983 Jan; 24(1):61-6. PubMed ID: 6129180
[TBL] [Abstract][Full Text] [Related]
73. Peptic ulcer healing with ranitidine in cimetidine resistance.
Witzel L; Wolbergs E
Lancet; 1982 Nov; 2(8309):1224. PubMed ID: 6128531
[No Abstract] [Full Text] [Related]
74. A prospective randomised controlled study of the use of ranitidine in patients with gastric cancer. Yorkshire GI Tumour Group.
Primrose JN; Miller GV; Preston SR; Gokhale J; Ambrose NS; Ward UM; Mills JG; Ehsanullah RS; Darekar B
Gut; 1998 Jan; 42(1):17-9. PubMed ID: 9505879
[TBL] [Abstract][Full Text] [Related]
75. Safety of nizatidine in clinical trials conducted in the USA and Europe.
Cloud ML
Scand J Gastroenterol Suppl; 1987; 136():29-36. PubMed ID: 2892253
[TBL] [Abstract][Full Text] [Related]
76. Influence of ranitidine on plasma metoprolol concentrations.
Jack D; Mitchard M; Smith RN
Br Med J (Clin Res Ed); 1983 Jun; 286(6383):2064. PubMed ID: 6135484
[No Abstract] [Full Text] [Related]
77. Systemic high-dose ranitidine in the treatment of psoriasis: an open prospective clinical trial.
Kristensen JK; Petersen LJ; Hansen U; Nielsen H; Skov PS; Nielsen HJ
Br J Dermatol; 1995 Dec; 133(6):905-8. PubMed ID: 8547042
[TBL] [Abstract][Full Text] [Related]
78. The safety of ranitidine in elderly versus non-elderly patients.
Sirgo MA; Mills R; Euler AR; Walker S
J Clin Pharmacol; 1993 Jan; 33(1):79-83. PubMed ID: 8429119
[TBL] [Abstract][Full Text] [Related]
79. H2 receptor antagonists for portal hypertension.
Schneider RE; Bishop H
Lancet; 1981 Jul; 2(8238):152. PubMed ID: 6113512
[No Abstract] [Full Text] [Related]
80. Ranitidine in short supply: why now, and where next?
Ryan ME; Barker C; Hawcutt DB
Arch Dis Child; 2020 Apr; 105(4):382-383. PubMed ID: 31848148
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
